Clear Harbor Asset Management, LLC Astrazeneca PLC Transaction History

Clear Harbor Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	BUY	$61.89 - $69.28 $35,586 - $39,836	575 Added 16.67%	4,025 $271,000
Q3 2023 Oct 26, 2023	SELL	$64.85 - $71.7 $3,242 - $3,585	-50 Reduced 1.43%	3,450 $233,000
Q2 2023 Jul 21, 2023	BUY	$69.91 - $75.81 $244,685 - $265,335	3,500 New	3,500 $250,000
Q4 2020 Feb 04, 2021	SELL	$48.52 - $58.02 $24,260 - $29,010	-500 Closed	0 $0
Q3 2020 Oct 26, 2020	BUY	$53.07 - $61.1 $26,535 - $30,550	500 New	500 $27,000
Q1 2020 May 08, 2020	SELL	$37.79 - $51.33 $18,895 - $25,665	-500 Closed	0 $0
Q4 2019 Jan 29, 2020	BUY	$42.46 - $50.46 $21,230 - $25,230	500 New	500 $24,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Clear Harbor Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Clear Harbor Asset Management, LLC with notifications on news.